Literature DB >> 9455870

Antibody responses to DNA in normal immunity and aberrant immunity.

D S Pisetsky1.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9455870      PMCID： PMC121381          DOI： 10.1128/CDLI.5.1.1-6.1998

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  51 in total

1.  Patterns of heavy and light chain utilization in the antibody response to single-stranded bacterial DNA in normal human subjects and patients with systemic lupus erythematosus.

Authors:  C R Robertson; G S Gilkeson; M M Ward; D S Pisetsky
Journal:  Clin Immunol Immunopathol       Date:  1992-01

2.  Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo.

Authors:  D Vlahakos; M H Foster; A A Ucci; K J Barrett; S K Datta; M P Madaio
Journal:  J Am Soc Nephrol       Date:  1992-02       Impact factor: 10.121

Review 3.  Anti-DNA antibodies in systemic lupus erythematosus.

Authors:  D S Pisetsky
Journal:  Rheum Dis Clin North Am       Date:  1992-05       Impact factor: 2.670

4.  Molecular characterization of anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. Differences from spontaneous anti-DNA in the content and location of VH CDR3 arginines.

Authors:  G S Gilkeson; D D Bloom; D S Pisetsky; S H Clarke
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

Review 5.  Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

Authors:  C A Stein; Y C Cheng
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

6.  Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms.

Authors:  R M Termaat; K J Assmann; H B Dijkman; F van Gompel; R J Smeenk; J H Berden
Journal:  Kidney Int       Date:  1992-12       Impact factor: 10.612

7.  DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth.

Authors:  S Yamamoto; T Yamamoto; S Shimada; E Kuramoto; O Yano; T Kataoka; T Tokunaga
Journal:  Microbiol Immunol       Date:  1992       Impact factor: 1.955

8.  Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity.

Authors:  S Yamamoto; T Yamamoto; T Kataoka; E Kuramoto; O Yano; T Tokunaga
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

9.  Heterologous protection against influenza by injection of DNA encoding a viral protein.

Authors:  J B Ulmer; J J Donnelly; S E Parker; G H Rhodes; P L Felgner; V J Dwarki; S H Gromkowski; R R Deck; C M DeWitt; A Friedman
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

10.  Specificity analysis of antibodies to single-stranded micrococcal DNA in the sera of normal human subjects and patients with systemic lupus erythematosus.

Authors:  C R Robertson; D S Pisetsky
Journal:  Clin Exp Rheumatol       Date:  1992 Nov-Dec       Impact factor: 4.473
View more
  8 in total

Review 1.  The antigenic properties of bacterial DNA in normal and aberrant immunity.

Authors:  D S Pisetsky
Journal:  Springer Semin Immunopathol       Date:  2000

2.  Antinucleosome antibodies and decreased deoxyribonuclease activity in sera of patients with systemic lupus erythematosus.

Authors:  Krisztina Sallai; Eszter Nagy; Beata Derfalvy; Györgyi Müzes; Peter Gergely
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

Review 3.  Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.

Authors:  Douglas B Cines; Keith R McCrae; X Long Zheng; Bruce S Sachais; Eline T Luning Prak; Don L Siegel
Journal:  Blood       Date:  2012-09-10       Impact factor: 22.113

4.  Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.

Authors:  E M Salonen; A Miettinen; T K Walle; S Koskenmies; J Kere; H Julkunen
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

Review 5.  B lymphocytes and systemic lupus erythematosus.

Authors:  Lisa G Criscione; David S Pisetsky
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

6.  Single-Molecule Interactions of a Monoclonal Anti-DNA Antibody with DNA.

Authors:  Tatiana A Nevzorova; Qingze Zhao; Yakov A Lomakin; Anastasia A Ponomareva; Alexander R Mukhitov; Prashant K Purohit; John W Weisel; Rustem I Litvinov
Journal:  Bionanoscience       Date:  2016-10-11

7.  Post-genomic platform for development of oligonucleotide vaccines against RNA viruses: diamond cuts diamond.

Authors:  V V Oberemok; O A Andreeva; K V Laikova; I A Novikov; A V Kubyshkin
Journal:  Inflamm Res       Date:  2022-05-06       Impact factor: 6.986

8.  Administration of M. leprae Hsp65 interferes with the murine lupus progression.

Authors:  Eliana B Marengo; Luciana V de Moraes; Marcella Faria; Beatriz L Fernandes; Luciana V Carvalho; Denise V Tambourgi; Luiz V Rizzo; Fernanda C V Portaro; Antônio Carlos M Camargo; Osvaldo A Sant'anna
Journal:  PLoS One       Date:  2008-08-21       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.